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How to Manage Failure*
Bimmer E. Claessen, MD,†
George D. Dangas, MD, PHD†‡
New York, New York
More than 30 years ago, thrombotic occlusion of a coronary
artery was identified as the pathophysiological mechanism
causing myocardial infarction (1). Mechanical and/or throm-
bolytic reperfusion has subsequently become the standard of
care for patients with ST-segment elevation myocardial
infarction (STEMI). However, reperfusion of the epicardial
coronary artery does not guarantee reperfusion at the myo-
cardial tissue level. Distal embolization of atherothrombotic
debris after primary percutaneous coronary intervention
(PCI) contributes significantly to the occurrence of micro-
vascular obstruction, which occurs in 15% to 70% of cases,
depending on the sensitivity of the diagnostic modality
used, and is associated with a worse prognosis (2,3).
See page 634
Distal protection devices and mechanical thrombectomy
have not succeeded in improving clinical outcome after
primary PCI in STEMI (4). However, the use of relatively
simple manual thrombectomy devices, which also facilitate
direct stenting, has been shown to improve angiographic
markers of reperfusion and improve survival compared with
primary PCI alone in a number of trials and meta-analyses
(5–7). In the 2009 update of the American College of
Cardiology/American Heart Association guidelines for the
management of patients with STEMI, thrombus aspiration
(TA) received a Class IIa, Level of Evidence: B recommen-
dation (8). However, a recent meta-analysis using more
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disclose.conservative Bayesian methods failed to show a significant
survival benefit with manual TA (9).
In light of these somewhat conflicting data, 1 potentially
important factor hitherto largely unexplored is failure of
attempted manual TA. Failure to reach and/or cross the
culprit lesion occurs in approximately 4% to 11% of patients
according to previous studies that reported this information
(10,11). Moreover, after successful deployment of the de-
vice, thrombotic material cannot be collected in approxi-
mately 25% of patients (7).
In this issue of JACC: Cardiovascular Interventions, Vink
et al. (12) report predictors and clinical significance of failed
TA in primary PCI for STEMI. In this report from a large,
single-center STEMI registry, the TA catheter failed to
reach and/or cross the culprit lesion in 10.3% of cases. The
investigators identified several lesion-specific characteristics
such as tortuosity, calcification, and bifurcations as indepen-
dent predictors of failure to reach and/or cross the coronary
lesion with the TA catheter. Moreover, no thrombus
material could be retrieved in 27.3% of patients in whom the
TA catheter successfully crossed the lesion. Age older than
60 years and the circumflex artery as the culprit vessel were
predictors of the lack of aspirate after successful deployment
of the TA catheter.
The clinical relevance of failed TA is still unclear. The
1-year mortality rate was similar in patients with successful
TA with aspirate (6.3%), successful TA without aspirate
(6.7%), and failed TA (6.2%). Multiple explanations can be
hypothesized to explain this finding. First, successful TA
with debris aspiration might have reduced mortality in
STEMI patients with large thrombus burdens to compara-
ble levels of mortality as seen in presumably not-as-
thrombotic lesions (i.e., in stiffer arteries, uncrossable by the
TA catheters) in which no debris could be aspirated.
Second, the relatively small sizes of the failed TA (n 144)
and successful TA without aspirate (n  283) groups could
mean that the study was underpowered to detect meaningful
differences in the 1-year mortality rates.
After the identification of predictors of TA failure, the
question remains whether the failure rate can be limited.
Although 3 different TA catheters were used in this study,
its retrospective nature and differences in device design
precluded a comparison of failure rates among the devices.
Hypothetically, improved TA devices engineered for opti-
mized delivery may increase success rates. Likewise, im-
proved aspiration capacity of manual TA devices may lead
to an increased yield of thrombotic debris. Moreover,
success rates will intuitively increase with operator experi-
ence. However, the present study did not investigate whether
higher operator volume increases TA success rates.
An important limitation of this study is the fact that TA
was not performed routinely, but rather at the discretion of
the operator. As a result, TA was only attempted in approxi-
mately one-third of primary PCIs. Therefore, predictors of
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644TA failure may be different in practices where TA is
performed routinely during primary PCI for STEMI. Ide-
ally, we would have liked to see a comparison between
patients in whom TA was attempted and those in whom it
was not. In light of this report, future TA trials should
collect data on failure to deliver the device and failure to
aspirate debris to clarify the uncertainties that currently still
remain.
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